Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/24 19:21 | 4/11/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | 2 | P.d | 15,152 | 0.5180 | 0 | 29,248 | 41 | 100,366 | M | |||||||||||||||
4/15/24 06:04 | 4/11/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | 1 | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | ||||||||||||||
4/15/24 06:02 | 4/11/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | 2 | P | 188 | 0.6618 | 0 | 284 | 102 | 562 | D | |||||||||||||||
6/15/23 20:13 | 6/14/23 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | 2 | P | 14 | 0.2468 | 0 | 55 | 11 | 563 | D | |||||||||||||||
4/7/23 17:12 | 4/5/23 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | 1 | P | 200 | 0.3017 | 0 | 663 | 5 | 14,829 | I | |||||||||||||||
12/28/22 16:05 | 12/23/22 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Gutfreund John Peter | CA | D | 1 | P | 25 | 0.3297 | 0 | 75 | 75 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |